OUR TEAM
RESPONSIVE. INSIGHTFUL. PERSONAL.
OUR TEAM
RESPONSIVE. INSIGHTFUL. PERSONAL.
LBRIA’s Senior Management team participate actively in studies and assume Project Management roles, monitoring, quality assurance roles, a multi-faceted approach across studies. They are highly trained and provide direction, resolve issues and understand the FDA expectations at sites.
BOARD OF DIRECTORS
Lois Rosenberger MS, PhD.
Board Member LBRIA.
Founder LBR.
Stephen Rosenberger BS, JD.
Board Member LBRIA.
Founder LBR.
Jim Dancy BSE, MBA.
Board Member LBRIA.
Founder IA.
Jeff Rosenberger BS,JD.
CEO LBRIA.
EXECUTIVE TEAM
Cathy Johnson BS.
Executive Director,
Quality Assurance / eTMF.
Beth Mack PharmD.
Executive Director,
Clinical Department.
Greg Elfring MS.
Executive Director,
Clinical SAS Programming.
Billee Parker MS.
Executive Director,
Clinical Data Management.
Greg Kelso PhD.
Vice President,
Regulatory Affairs & Medical Writing.
Sue Thayer MS.
Executive Director,
Business Development
Kim Perry PhD.
Executive Director,
Clinical Biostatistics.
INDUSTRY-EXPERIENCE TEAMS
LBRIA’s team of more than 50 full-time professionals brings extensive experience across drug development, clinical project management, site management, regulatory affairs, and quality assurance. We align the right expertise to each program, ensuring seamless integration with sponsor teams and efficient issue resolution throughout the project lifecycle.